Stay updated on ADVOCATE: Avacopan Clinical Trial
Sign up to get notified when there's something new on the ADVOCATE: Avacopan Clinical Trial page.

Latest updates to the ADVOCATE: Avacopan Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedLocations are now presented under a single consolidated 'Locations' section listing all states; previously there were separate state-specific location subsections. The HHS Vulnerability Disclosure link was removed and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference1.0%

- Check69 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and included the Revision: v3.3.2 tag; replaced the previous PubMed description and removed Revision: v3.2.0.SummaryDifference0.0%

- Check77 days agoChange DetectedThe government funding status notice was removed from the page. Core study details, contacts, and locations are unchanged.SummaryDifference0.1%

- Check99 days agoChange DetectedThe observed changes consist mainly of formatting adjustments and minor content updates on the study page, with no alterations to core details such as eligibility criteria, primary outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check113 days agoChange DetectedAdded a new reference to a study on avacopan for ANCA-associated vasculitis (ADVOCATE Study Group) with full citation and DOI.SummaryDifference0.8%

Stay in the know with updates to ADVOCATE: Avacopan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVOCATE: Avacopan Clinical Trial page.